NCT03767491

Brief Summary

The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for obsessive compulsive disorder (OCD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in Y-BOCS scores than those in the waitlist condition at treatment endpoint (week 12).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 6, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

August 8, 2022

Status Verified

May 1, 2020

Enrollment Period

2.9 years

First QC Date

December 5, 2018

Last Update Submit

August 4, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in OCD severity (Y-BOCS) at the end of treatment/waitlist period.

    The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is the gold-standard, semi-structured clinician-administered assessment of OCD severity. It contains 10 items ranging from 0 to 4, which are summed to generate a total score (range = 0-40). Higher scores indicate more severe OCD symptoms. The Y-BOCS will be used to assess change in OCD symptoms from baseline to endpoint.

    Endpoint (week 12)

Secondary Outcomes (3)

  • Difference in depression at the end of treatment/waitlist period

    Endpoint (week 12)

  • Difference in functional impairment at the end of treatment/waitlist period

    Endpoint (week 12)

  • Difference in quality of life at the end of treatment/waitlist period

    Endpoint (week 12)

Study Arms (2)

Smartphone-delivered CBT for OCD

EXPERIMENTAL

12-week Smartphone delivered CBT for OCD.

Device: Smartphone-delivered CBT for OCD

12 Week Waitlist Control

OTHER

12-week waitlist control. (Note: participants will be crossed over to 12-week Smartphone-delivered CBT for OCD following the 12-week waitlist control).

Device: Smartphone-delivered CBT for OCD

Interventions

12-week Smartphone-delivered CBT for OCD. In-person cognitive-behavioral therapy (CBT) is an empirically supported treatment for OCD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.

12 Week Waitlist ControlSmartphone-delivered CBT for OCD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • at least 18 years of age
  • current diagnosis of primary DSM-5 OCD, based on MINI
  • currently living in the United States

You may not qualify if:

  • Psychotropic medication changes within 2 months prior to enrollment (Participants taking psychotropic medication must have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period)
  • Past participation in ≥ 4 sessions of CBT for OCD
  • Current severe substance use disorder
  • Lifetime bipolar disorder or psychosis
  • Acute, active suicidal ideation as indicated by clinical judgment and/or a score ≥ 2 on the suicidal ideation subscale of the C-SSRS
  • Current severe comorbid major depression, as indicated by clinical judgment and/or a QIDS-SR total score ≥ 21
  • Concurrent psychological treatment
  • Does not own a supported mobile Smartphone with a data plan
  • Lack of technology literacy that would interfere with ability to engage with smartphone treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anna Schwartzberg

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Sabine Wilhelm, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Psychology

Study Record Dates

First Submitted

December 5, 2018

First Posted

December 6, 2018

Study Start

July 1, 2019

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

August 8, 2022

Record last verified: 2020-05

Locations